FDA Approves Over-The-Counter Tavist (Clemastine Fumarate) For Allergy, Sinus Headache
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




FDA Approves Over-The-Counter Tavist (Clemastine Fumarate) For Allergy, Sinus Headache

SUMMIT, NJ -- March 9, 2001 -- Novartis Consumer Health announced that the U.S. Food and Drug Administration (FDA) has granted approval of Tavist® Allergy/Sinus/Headache for marketing over-the-counter.

Tavist Allergy/Sinus/Headache is the only over-the-counter medication to combine the antihistamine clemastine fumarate with a nasal decongestant and pain reliever. It is indicated for treatment of allergies, sinus congestion and pressure, runny nose and sneezing, itchy, watery eyes, and itchy throat. The product began shipping to stores nationwide immediately upon FDA approval and will be found on store shelves within weeks.

Tavist Allergy/Sinus/Headache, as with all Tavist products, is PPA-free, utilizing pseudoephedrine hydrochloride as the active decongestant ingredient. The Tavist brand line also includes Tavist® Sinus and Tavist® Allergy. Tavist brand products have been marketed over the counter in the U.S. since 1992.

"With the launch of Tavist Allergy/Sinus/Headache, for the first time consumers can now choose a Tavist product that will provide complete relief of their allergy and sinus symptoms, as well as pain relief," said Barry Cohen, North American OTC Category Vice President for Novartis Consumer Health. "Consumers have placed a high level of trust and confidence in Tavist over-the-counter medications for nearly a decade, and we are certain this new Tavist product will provide them with the same quality of care they have come to expect."

Related Link: Novartis.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities